Cancer News: Breaking Cancer News, Comments and Articles. - Page: 3

Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients

WHITE PLAINS, N.Y. , June 19, 2013 /- This year alone, The Leukemia & Lymphoma Society (LLS) is supporting more than 300 research projects with one goal in mind: Discovering lifesaving therapies for blood cancer patients. And in 2013, "Team...

New blood test detects colon cancer before it develops

DALLAS, June 19, 2013 /PRNewswire-USNewswire/ -- A new blood test developed in the Gastrointestinal Cancer Research Lab at Baylor Research Institute is showing very promising results for finding cancer-related microRNA in the blood before a tumor develops in the colon. (Photo: http://photos.prnewswire.com/prnh/20130619/DC33230) The test results, published in the latest issue of the Journa...

Aurigene and Debiopharm Group™ Report Nomination of Development Candidate Debio 0617B in Oncology

LAUSANNE, Switzerland and BANGALORE, India, June 19, 2013 /PRNewswire/ -- Aurigene Discovery Technologies, a Bangalore-based biotech focusing on small molecule and peptide drug discovery and Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced the succe...

Celldex Turning Into A Compelling Immunotherapy Biotech

By Stephen Simpson:"Shoulda, coulda, woulda" will probably be my investing epitaph. While there is no shortage of investment advice telling you that long-term investment success is predicated on developing a consistent method of evaluating stocks and sticking to your valuation guns, the consequences can be painfulA perfect case in point is Celldex Therapeutics (CLDX). I've always liked this develo...

"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference

SAN FRANCISCO, June 19, 2013 /PRNewswire/ -- It may seem like an odd pairing: an oral growth hormone-boosting supplement and possible cure for breast cancer. But these were two of the most talked about topics at ENDO 2013, The Endocrine Society's 95th Annual Meeting & Expo that just convened in San Francisco. And now some are saying this focus by some of the top internal medicine experts...

The American Academy of Anti-Aging Medicine (A4M) Wrapped up Bio-Identical Hormone Replacement Therapy (BHRT) Symposium in San Diego, CA Sunday, June 9th

Boca Raton, FL, June 19, 2013 --(PR.com)-- This four day conference at the San Diego Marriott Hotel and Marina welcomed over 400 medical professionals, including doctors, nurse practitioners, and pharmacists from all over the world as they prepared to learn from dozens of medical experts from various different specialties. The speakers presented discussions on many different topics ranging from h...

Japan Ministry Still Puzzled By Adverse HPV Vaccine Reactions

Japan's suspension of a program urging cervical-cancer vaccinations continues as the health ministry struggles to understand the causes of adverse side effects that led to the response.

Exposing tissue to low levels of BPA linked to greater incidence of prostate cancer

Exposing developing tissue to low levels of the plastic bisphenol A, commonly known as BPA, is linked to a greater incidence of prostate cancer in tissue grown from human prostate stem cells, a new study finds. The results were presented Monday, June...

Researchers identify biochemical pathway essential for promoting head and neck cancer

A study led by researchers at The Ohio State University Comprehensive Cancer Center-- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute has identified a biochemical pathway in cancer stem cells that is essential for promoting h...

Increased Risk Of Prostate Cancer In Human Stem Cells Following Exposure To Low Doses Of BPA

Exposing developing tissue to low levels of the plastic bisphenol A, commonly known as BPA, is linked to a greater incidence of prostate cancer in tissue grown from human prostate stem cells, a new study finds. The results were presented at The Endoc...

Research findings may pave way for new strategy to combat lung cancer

Recent research has shown that cancer cells have a much different - and more complex - metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might provide a new strategy to com...

Longer-Term Tamoxifen Improves Breast Cancer Outcomes

For women with early-stage, estrogen receptor-positive (ER-positive) breast cancer, ten years of adjuvant tamoxifen appears to be more effective than the standard five years. These results were presented at the 2013 Annual Meeting of the American Soc...

Roche Experimenting With New Pricing Models In Oncology

Cancer drug prices are unsustainable and creative approaches are needed, Roche’s COO Daniel O’Day says. The firm’s moves into emerging markets are a lab for new methods, though the real test will come as the more expensive drugs are used in com...

Self-Testing for HPV

Teaching Kenyan women to collect their own genital specimens to be used in testing for human papillomavirus (HPV)—the primary risk factor for cervical cancer—shows promise in the detection of this malignancy and could help lower the high rate of...

Incidence Rate of Breast Cancer in Young Women—Reply

In Reply: Drs Hou and Huo suggest that we should correct for missing data on receptor status in the SEER database. Using the method cited by Hou and Huo, we calculated that for 25- to 39-year-old women diagnosed with distant stage breast cancer durin...

Incidence Rate of Breast Cancer in Young Women

To the Editor: Dr Johnson and colleagues concluded that there has been a significant increase in the incidence of ER+ breast cancer with distant involvement for women aged 25 to 39 years between 1976 and 2009 and urged further study of potential caus...

General Health Checks in Adults for Reducing Morbidity and Mortality From Disease General Health Checks in Adults

Clinical QuestionWhat are the benefits and harms of general health checks for adult populations?Bottom LineCompared with usual care, offers of health checks were not associated with lower rates of all-cause mortality, mortality from cardiovascular di...

TG Therapeutics, Inc. Announces Presentation of Pre-Clinical Data on the Combination of TG-1101 and TGR-1202 at the International Conference on Malignant Lymphoma, Lugano, Switzerland

NEW YORK, June 19, 2013 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX), an innovative, clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs, today announced pre-clinical data on the combination of TG-1101 plus TGR-1202 was pr...

Intezyne Technologies Expands Its Oncology Pipeline Through Strategic Acquisition of Niiki Pharma

Niiki Pharma brings two first-in-class clinical-stage oncology products to Intezyne Intezyne's product pipeline now includes one Phase 2-ready compound, one Phase 1-ready compound, one pre-IND compound, and three preclinical compounds Niiki Pharma's co-founder joins Intezyne as Chief Development Officer TAMPA, Fla., June 19, 2013 (GLOBE NEWSWIRE) -- Intezyne Technologies, a privat...

RedChip Issues Research Profile on Cancer Genetics

ORLANDO, Fla., June 19, 2013 (GLOBE NEWSWIRE) -- RedChip Companies, Inc., today announced it has issued a research profile on Cancer Genetics, Inc. (OTCQB:CGIX), an emerging leader in DNA-based cancer diagnostics and services. To receive a complimentary copy of the RedChip Research Report for CGIX, please visit: http://www.redchip.com/about/aboutmain.asp?rid=448 To learn more about Cancer Gen...

CVac(TM) CAN-003 Trial Selected for Oral Presentation at the European Cancer Congress

SYDNEY, AUSTRALIA -- (Marketwired) -- 06/19/13 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN: US74154B2034) ("Prima," the "Company") today announced that the abstract titled "Clinical study of autologous dendritic cell therapy targeting mucin 1 for treatment of ovarian cancer patients in first remission" has been selected by the European Cancer Congress Scientific Committee for oral present...

Genetic Technologies Executes Agreement With Further Nationwide Provider Network for BREVAGen(TM)

MELBOURNE, AUSTRALIA -- (Marketwired) -- 06/19/13 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that through its wholly-owned subsidiary Phenogen Sciences Inc. it has executed an agreement with FedMed Inc. of Rockville, Maryland to use the FedMed national provider network. FedMed Inc. is a national provider network that includes more than 550,000 physicians, 60...

Certain Types Of Graft-Versus-Host Disease May Increase Risk Of Death

Joseph Pidala, M.D., M.S., assistant member of the Blood and Bone Marrow Transplant and Immunology programs at Moffitt Cancer Center, and colleagues from the Chronic Graft-Versus-Host Disease Consortium have determined that certain gastrointestinal a...

Minimally Invasive Techniques Allow Doctors To Remove Suspicious Polyps, Keep Colon Intact

Millions of people each year have polyps successfully removed during colonoscopies. But when a suspicious polyp is bigger than a marble or in a hard-to-reach location, patients are referred for surgery to remove a portion of their colon - even if doc...

'Undruggable' To Druggable: A New Target For Cancer Drug Development

Harvard Stem Cell Institute (HSCI) researchers have identified in the most aggressive forms of cancer a gene known to regulate embryonic stem cell self-renewal, beginning a creative search for a drug that can block its activity. The gene, SALL4, give...